Insights

In-depth interviews with decision-makers, stakeholders, and researchers on timely and emerging trends in clinical data, health policy, value-based care, and more!

Current Treatment Regimens for Multiple Myeloma

July 25th 2018Current Treatment Regimens for Multiple Myeloma

Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC

July 18th 2018Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC

Personalized Selection of Upfront Therapy in CLL

July 11th 2018Personalized Selection of Upfront Therapy in CLL

PARP Inhibitors in the Management of Ovarian Cancer

November 28th 2017PARP Inhibitors in the Management of Ovarian Cancer

Perspectives in the Management of Non-Small Cell Lung Cancer

May 12th 2017Perspectives in the Management of Non-Small Cell Lung Cancer

Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation

April 18th 2017Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation

Clinical Progress and Coverage Policies in Immuno-Oncology

July 28th 2016Clinical Progress and Coverage Policies in Immuno-Oncology

Updates in the Treatment of Pulmonary Arterial Hypertension

July 18th 2016Updates in the Treatment of Pulmonary Arterial Hypertension

Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

July 18th 2016Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

Current Clinical Landscape and Managed Care Approach in Multiple Myeloma

July 6th 2016Current Clinical Landscape and Managed Care Approach in Multiple Myeloma

Updates in the Management of Type 2 Diabetes Mellitus and Comorbid
Dyslipidemia

May 27th 2016Updates in the Management of Type 2 Diabetes Mellitus and Comorbid Dyslipidemia

The Evolution and Clinical Impact of Diagnostic Testing

October 29th 2015The Evolution and Clinical Impact of Diagnostic Testing

Treatment for Patients With Thromboembolic Complications

July 24th 2015Treatment for Patients With Thromboembolic Complications

Use of Oral Oncolytics In Palliative Care

June 10th 2015Use of Oral Oncolytics In Palliative Care

The Clinical and Reimbursement Landscape of Immuno-Oncology

May 26th 2015The Clinical and Reimbursement Landscape of Immuno-Oncology

Innovative Payment Models in Oncology

May 13th 2015Innovative Payment Models in Oncology

Innovation and Role of Alternative Markers of Efficacy

January 23rd 2015Innovation and Role of Alternative Markers of Efficacy

Assessing the Clinical Utility of Companion Diagnostics

January 16th 2015Assessing the Clinical Utility of Companion Diagnostics

New Standards of Care in the Management of Prostate Cancer

December 17th 2014New Standards of Care in the Management of Prostate Cancer

Defining the Value of Innovation in Oncology

November 6th 2014Defining the Value of Innovation in Oncology

Transitions of Care Challenges in Cardiology

April 30th 2014Transitions of Care Challenges in Cardiology

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions